1.Series interpretation to Chinese Expert Consensus on the Diagnosis and Treatment of Acromegaly(2020)(Part 4): Diagnosis and treatment of acromegaly
Chinese Journal of Endocrinology and Metabolism 2021;37(5):429-431
In 2020, the Chinese Society of Endocrinology released a new version of the consensus on acromegaly. This article aims to interpret in details on three aspects of treatment goals, surgical treatment, and radiotherapy in this concensus.
2.Quantitative study of adiponectin mRNA expression in subcutaneous and omental adipose tissues of patients with type 2 diabetes
Wei GU ; Wenheng ZENG ; Tohru FUNAHASHI
Chinese Journal of Endocrinology and Metabolism 2001;0(05):-
Objective To study the adiponectin mRNA expression in subcutaneous and omental adipose tissues of type 2 diabetes and their relation with blood adiponectin, body weight index, waist hip ratio and insulin sensitivity. Methods The adiponectin mRNA expression level in adipose tissue of 22 cases with type 2 diabetes and 26 cases of non diabetes controls was assayed by real time fluorescence quantitative RT PCR. The level of plasma adiponectin was measured with ELISA kit. Results The adiponectin mRNA expression in omental adipose tissue was significantly decreased in patients with type 2 diabetes than that in non diabetes controls (P
3.Continuous glucose monitoring in type 2 diabetes with gastroparesis
Wenheng ZENG ; Xiaowen HE ; Jie SHEN ; Wei GU
Chinese Journal of Internal Medicine 2008;47(5):397-400
Objective To observe the glucose profile in type 2 diabetic gastroparesis.Methods 31 patients diagnosed with type 2 diabetes were enrolled into this study for measurement of gastric emptying of solids and continuous glucose monitoring to observe blood glucose 1evels for 72 hours on a balanced diet;the results were compared with 7 subjects with norinal glucose regulation.Results 58.1%of 31 type 2 diabetic patients were found to have delayed gastric emptying of solids.The average glucose level was lower after breakfast[(7.82±1.42)mmol/L vs(9.35±2.28)mmol/L,P<0.01]in the patients with gastroparesis than in those without.Maximal blood glucose level after breakfast[(10.21±2.17)mmol/L vs (12.24±2.82)mmol/L,P<0.01]was lower in the patients with gastroparesis but it reached the peak at a similar time.Two hour AUC was also lower after breakfast in the patients with gastroparesis[(877.62±Post-prandial glucose levelin type 2 diabetic patients with gastroparesis tends to be lower than those without.
4.The effect of adult growth hormone deficiency on cognitive function
Hui ZHOU ; Xiaoxiao SONG ; Peiyu HUANG ; Wenheng ZENG ; Huiling SHEN ; Linjin WU ; Wei GU
Chinese Journal of Endocrinology and Metabolism 2023;39(3):249-255
Objective:To explore the effect of adult growth hormone deficiency on cognitive function in adults.Methods:A total of 19 hypophyseal or craniopharyngioma patients who underwent surgical treatment and were diagnosed with adult growth hormone deficiency in Department of Endocrinolog, the Second Affiliated Hospital, School of Medicine, Zhejiang University from June 2017 to June 2018 were selected as the case group, and 19 normal people were included as the control group. All the members were assessed with the cognitive function scale and brain functional magnetic resonance examination, data between the groups were analyzed.Results:The body weight within a year of case group was significantly increased than that of the control group( P=0.017). Compared with the control group, the case group was relatively inattentive and had decreased memory(Time of stroop color words test-a, test-c, and trail-making test-A, P values were 0.009, 0.018, 0.020 respectively; Auditory word learning test N6, P=0.008). The executive function and language ability of the case group were weakened compared with the control group(Raven′s matrices score E1-E12, P=0.022; Time cost and the number of arrivals in 1 min of connection test B, P values were 0.023, 0.004; Symbol digit modalities test, P=0.037; The number of words spoken in 46-60 s and total number in 0-60 s of the case group was less than the control, P values were 0.030, 0.006). The general mental state of the case group was worse than the control group( P=0.018). The accuracy of the 2-back task of the case group was significantly lower and the activation signal of the left frontal lobe in the case group was significantly weaker( P<0.005). Conclusions:Adult growth hormone deficiency may increase obesity risk and have a detrimental influence on patients′ overall mental health, resulting in varying degrees of cognitive impairment. Working memory impairments associated with adult growth hormone deficiency may be a result of decreased frontal lobe brain activity.
5.Metabolic syndrome increases Framingham risk score of patients with type 2 diabetes mellitus.
Yao MEIFANG ; Sun XUE ; Han JUE ; T U YINA ; H E JIE ; Zhao YIMING ; Lou HANYU ; Pang XIAOHONG ; Zeng WENHENG ; Zhang SONGZHAO ; Shan PENGFEI
Journal of Zhejiang University. Medical sciences 2016;45(3):268-274
OBJECTIVETo assess the impact of metabolic syndrome(MS) on Framingham risk score(FRS) in patients with type 2 diabetes mellitus (T2DM).
METHODSThe anthropometric and biochemical data of 1708 patients with T2DM admitted in hospital from May 2008 to April 2013 were retrospectively analyzed, including 902 males and 806 females with a mean age of 57.1±11.8 years (20-79 years). Diagnosis of MS was made according to the criteria of the Adult Treatment Panel Ⅲ Criteria modified for Asians.
RESULTSCompared to non-MS/T2DM patients, MS/T2DM patients had higher waist circumference, body weight, body mass index, systolic and diastolic blood pressure, fasting C peptide, total cholesterol, triglyceride, and LDL-C (P<0.05), while lower HDL-C (P<0.01). Both FRS [13.0(10.0, 15.0) vs 11.0(9.0, 13.0) in male,15.0(12.0, 18.0) vs 12.0(6.0, 14.8) in female,P<0.01)] and 10-year cardiovascular risk [12.0%(6.0%, 20.0%) vs 8.0%(5.0%,12.0%) in male,3.0%(1.0%, 6.0%) vs 1.0%(0.0%, 2.8%) in female,P<0.01] were higher in MS/T2DM patients than those in non-MS/T2DM patients.Both FRS and 10-year cardiovascular risk were increased with the components of MS.
CONCLUSIONT2DM patients with MS have more cardiovascular risk factors, higher FRS and 10-year cardiovascular risk.